MiR-101 promotes nasopharyngeal carcinoma cell apoptosis through inhibiting Ras/Raf/MEK/ERK signaling pathway.
Extra-cellular signal regulated kinase (ERK)/mitogen activated protein kinase (MAPK) signaling pathway is widely involved in cell proliferation and apoptosis. MAPK kinase 1 (MEK1) is the upstream protein kinase of ERK that can activate ERK/MAPK signaling pathway. microRNA-101 (MiR-101) down-regulation is found to be associated with nasopharyngeal carcinoma (NPC) pathogenesis. Bioinformatics analysis shows the complementary targeted relationship between miR-101 and the 3'-UTR of MEK1 mRNA. This study explores the role of miR-101 in regulating MEK1 expression, ERK/MAPK signaling pathway activation, and NPC pathogenesis. Dual luciferase assay confirmed the targeted relationship between miR-101 and MEK1. MiR-101 and MEK1 expressions were compared in inflammatory nasopharynx tissue and NPC tissue. MiR-101, MEK1, phosphorylated ERK 1/2 (p-ERK1/2), survivin expressions in NP69, CNE-1, HONE1, and C666-2 cell lines were detected. NPC cell line C666-1 was cultured in vitro and divided into four groups, including miR-NC, miR-101, si-NC and si-MEK1. Cell apoptosis was determined by flow cytometry. Cell proliferation was evaluated by EdU staining. MiR-101 targeted inhibited MEK1 expression. MiR-101 was significantly down-regulated, while MEK1 was significantly elevated in NPC tissue compared with inflammatory nasopharynx tissue. MiR-101 was markedly declined, whereas MEK1, p-ERK1/2, and survivin were apparently increased in CNE-1, HONE1, and C666-1 cells compared with NP69 cells. MiR-101 mimic and/or si-MEK1 transfection significantly reduced MEK1, p-ERK1/2, and survivin levels, attenuated cell proliferation, and enhanced cell apoptosis. Down-regulation of miR-101 was related to NPC pathogenesis. MiR-101 elevation suppressed NPC cell proliferation and promoted apoptosis through targeted inhibiting MEK1 expression to alleviate ERK/MAPK signaling pathway and survivin expression.